Zealand Pharma A/S
(OTCPK:ZLDPF)
$
90.7
2.025 (2.28%)
Market Cap: 5.64 Bil
Enterprise Value: 5.21 Bil
PE Ratio: 0
PB Ratio: 13.48
GF Score: 56/100 
Q1 2024 Zealand Pharma A/S Earnings Call Transcript6 days ago$91.15 (-4.36%)Earnings- Full Year 2023 Zealand Pharma A/S Earnings Call TranscriptFeb 27, 2024$90 (-12.62%)Earnings
- Zealand Pharma A/S at Goldman Sachs Healthcare C-Suite Unscripted Conference TranscriptJan 04, 2024
- Zealand Pharma A/S Obesity R&D Event TranscriptDec 05, 2023
- Q3 2023 Zealand Pharma A/S Earnings Call TranscriptNov 09, 2023$41.91Earnings
- Zealand Pharma A/S at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Zealand Pharma A/S Earnings Call TranscriptAug 17, 2023$35.19 (-0.45%)Earnings
- Zealand Pharma A/S at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Zealand Pharma A/S at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 Zealand Pharma A/S Earnings Call TranscriptMay 11, 2023$35 (+7.36%)Earnings
- Zealand Pharma A/S at Needham Healthcare Conference (Virtual) TranscriptApr 19, 2023
- Zealand Pharma A/S Annual Shareholders Meeting TranscriptMar 29, 2023
- Q4 2022 Zealand Pharma A/S Earnings Call TranscriptMar 02, 2023$32Earnings
- Zealand Pharma A/S at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 Zealand Pharma A/S Earnings Call TranscriptNov 10, 2022$26.48Earnings
- Zealand Pharma A/S Corporate Call TranscriptSep 30, 2022
- Zealand Pharma A/S at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Zealand Pharma A/S Earnings Call TranscriptAug 11, 2022$18.3 (+0.94%)Earnings
- Q1 2022 Zealand Pharma A/S Earnings Call TranscriptMay 12, 2022$11.14Earnings
- Zealand Pharma A/S at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Zealand Pharma A/S Corporate Update Call TranscriptMar 30, 2022
- Q4 2021 Zealand Pharma A/S Earnings Call TranscriptMar 10, 2022$14.35Earnings
- Q3 2021 Zealand Pharma A/S Earnings Call TranscriptNov 11, 2021$27.5 (-13.11%)Earnings
- Zealand Pharma A/S at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Zealand Pharma A/S Earnings Call TranscriptAug 12, 2021$28.92Earnings
- Zealand Pharma A/S at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Q1 2021 Zealand Pharma A/S Earnings Call TranscriptMay 12, 2021$32.6Earnings
- Zealand Pharma A/S Corporate Call TranscriptMar 23, 2021
- Full Year 2020 Zealand Pharma A/S Earnings Call TranscriptMar 11, 2021$31.88Earnings
- Zealand Pharma A/S - Special Call TranscriptMar 05, 2021
- Zealand Pharma A/S - Pre Recorded Special Call TranscriptMar 04, 2021
- Q3 2020 Zealand Pharma A/S Earnings Call TranscriptNov 12, 2020$33.4Earnings
- Zealand Pharma A/S Presents at Morgan Stanley 18th Annual Global Healthcare Conference, Sep-14-2020 10:30 AM TranscriptSep 14, 2020
- Q2 2020 Zealand Pharma A/S Earnings Call TranscriptAug 13, 2020$35.63Earnings
- Q1 2020 Zealand Pharma A/S Earnings Call TranscriptMay 14, 2020$24.6Earnings
- Zealand Pharma A/S at Needham Healthcare Conference TranscriptApr 15, 2020
- Zealand Pharma A/S Annual Shareholders Meeting TranscriptApr 02, 2020
- Full Year 2019 Zealand Pharma A/S Earnings Call TranscriptMar 12, 2020$25.7 (-28.31%)Earnings
- Valeritas Holdings, Inc., Zealand Pharma A/S - M&A Call TranscriptFeb 10, 2020
- Q3 2019 Zealand Pharma A/S Earnings Call TranscriptNov 14, 2019$33.1 (+3.70%)Earnings
- Zealand Pharma A/S Expands Its Peptide Platform with Acquisition of Encycle Therapeutics Inc Call TranscriptOct 22, 2019
- Half Year 2019 Zealand Pharma A/S Earnings Call TranscriptAug 15, 2019$21.86Earnings
- Q1 2019 Zealand Pharma A/S Earnings Call TranscriptMay 16, 2019$20.42Earnings
- Zealand Pharma A/S - Special Call TranscriptMar 21, 2019
- Q4 2018 Zealand Pharma A/S Earnings Call TranscriptMar 07, 2019$13.77Earnings
Q1 2023 Zealand Pharma A/S Earnings Call Transcript
May 11, 2023 / 12:00PM GMT
Release Date Price:
$35
(+7.36%)
Operator
Hello, and welcome to the Zealand Pharma Conference Call. I would like to advise all participants that this call is being recorded. Thank you. I'd now like to welcome Anna Krassowska to begin the conference. Anna, over to you.
Anna Krassowska;S;VP of IR;Corporate Communications;Adam Sinding Steensberg;S;
Zealand Pharma A;Zealand Pharma A
/-&
Welcome, and thank you for joining us today to discuss Zealand's interim results for the first quarter of 2023. With me today are the following members of Zealand's management team, Adam Steensberg, President and Chief Executive Officer; Henriette Wennicke, Chief Financial Officer; and David Kendall, Chief Medical Officer. You can find the related company announcement and interim report on our website at zealandpharma.com. As described on Slide 2, we will be making forward-looking statements that are subject to risks and uncertainties. With that, I will turn the call over to Adam Sabre, President and CEO. Adam?
- /
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers